Antihypertensive treatment strategy and blood pressure control in patients with essential hypertension complicated by ischemic hemispheric stroke

Authors

  • V. V. Syvolap Zaporizhzhia State Medical University, Ukraine,
  • S. P. Zhemaniuk Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2019.3.168957

Keywords:

arterial hypertension, stroke, blood pressure, arterial pressure.

Abstract

The aim was to study the effectiveness of antihypertensive therapy in essential hypertensives in the acute phase of ischemic hemispheric stroke.

Material and methods. The first group included 18 patients (65 (59; 69) years, 61 % male) with arterial hypertension (AH) in the acute phase of ischemic hemispheric stroke who received antihypertensive monotherapy. The second group included 14 AH patients (aged 61 (56; 71) years, 57 % male) in the acute phase of ischemic hemispheric stroke who received combination antihypertensive treatment. The effectiveness of antihypertensive therapy was evaluated on day 21 (12, 30) of the stroke onset by “office” blood pressure (BP) measurement. In order to identify the covariates associated with the probability of target BP level achieving at the end of the hospital period, binary logistic regression models were used.

Results. 61 % of patients (11/18) achieved the target BP level with monotherapy strategy and 64 % (9/14) achieved the target BP level with combination antihypertensive therapy, insignificant difference (P = 0.854). 24-hour systolic, diastolic, pulse, mean arterial pressure (MAP), calculated by empirical and Wezler–Böger formulas, were slightly higher in the group of patients receiving combined antihypertensive drugs, however, there was no significant difference (P = 0.262; P = 0.356; P = 0.880; P = 0.262; P = 0.279, respectively). Meanwhile, the groups were differed in the daytime MAP level calculated by two formulas (P = 0.032 and P = 0.040, respectively). According to the ROC-analysis, the cut-offs of daytime MAP was 102.4 mm Hg and 104.9 mm Hg, respectively. In the logistic regression analysis, the multivariate model adjusted for age, sex and status of diabetes mellitus, the monocomponent scheme (angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB)) was associated with the target BP level achievement in AH patients in the acute phase of ischemic hemispheric stroke (OR: 18.61; (DI: 3.36; 103.14), P = 0.001).

Conclusions. 63 % of AH patients treated with the first-line drugs in the acute phase of ischemic hemispheric stroke achieved the target BP level. Monocomponent antihypertensive therapy prescribed at the end of the acute hypertensive reaction in AH patients was as effective as combined strategy in achieving the target BP level by “office” measurements in the 2–4 weeks of the disease. The multivariate model adjusted for age, sex and status of diabetes mellitus which associated with target BP level achievement in AH patients in the acute phase of ischemic hemispheric stroke included a monocomponent scheme (ACEi or ARB). The cut-offs of daytime MAP calculated by empirical and Wezler–Böger formulas were 102.4 mm Hg and 104.9 mm Hg, respectively. The daytime MAP (24-hour BP monitoring) was the only parameter that was statistically higher in the group of combined treatment and so, can be the criterion for the combination therapy prescription in AH patients in the acute phase of ischemic hemispheric stroke.

 

References

Williams, B., Mancia, G., Spiering, W., Agabiti, R. E., Azizi, M., Burnier, M., et al. (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J, 39(33), 3021–3104. doi: 10.1093/eurheartj/ehy339

AlSibai, A., & Qureshi, A. (2016) Management of acute hypertensive response in patients with ischemic stroke. Neurohospitalist, 6(3), 122–129. doi: 10.1177/1941874416630029

Ministerstva okhorony zdorov’ia Ukrainy (2012) Unifikovanyi klinichnyi protocol medychnoi dopomogy: ischemichnyi insult (ekstrena, pervynna, vtorynna (spetsializovana) medychna dopomoha, medychna reabilitatsiia [Clinical protocol for medical ischemic stroke (emergency, primary, secondary (specialized) medical care, medical rehabilitation)]. Reteieved from http://old.moz.gov.ua/ua/portal/dn_20120803_602.html [in Ukrainian].

Kovalenko V. M., et al. (Eds) (2016) Sertsevo-sudynni zakhvoriuvannia. Klasifikatsiia, standarty diahnostyky ta likuvannia [Cardiovascular diseases: Classification, practical protocols of diagnosis and treatment]. Kyiv: Morion [in Ukrainian].

Parati, G., Stergiouc, G., O’Briend, Е. Asmar, R., Beilin, L., Bilo, G., et al. (2014) European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens, 32(7), 1359–136. doi: 10.1097/HJH.0000000000000221

Papaioannou, T., Protogerou, A., Vrachatis, D., Konstantonis, G., Aissopou, E., Argyris, A., et al. (2016) Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals. Hypertension Research, 39(9), 640–647. doi: 10.1038/hr.2016.41

He, J., Zhang, Y., Xu, T., Wang, D., Sun, Y., Chen, C. S., et al. (2014) Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA, 311(5), 479–489. doi: 10.1001/jama.2013.282543

Robinson, T., Potter, J., Ford, G., Bulpitt, C. J., Chernova, J., Jagger, C., et al. (2010) Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol, 9(8), 767–75. doi: 10.1016/S1474-4422(10)70163-0

Bath, P. M., Martin, R. H., Palesch, Y., Cotton, D., Yusuf, S., Sacco, R., et al. (2009) Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke, 40(11), 3541–3546. doi: 10.1161/STROKEAHA.109.555623

Sandset, E. C., Bath, P. M., Boysen, G., Cotton, D., Yusuf, S., Sacco, R., et al. (2011) The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet, 377(9767), 741–750. doi: 10.1016/S0140-6736(11)60104-9

Bath, P., & Krishnan, K. (2014) Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev, 10. CD000039. doi: 10.1002/14651858.

How to Cite

1.
Syvolap VV, Zhemaniuk SP. Antihypertensive treatment strategy and blood pressure control in patients with essential hypertension complicated by ischemic hemispheric stroke. Zaporozhye Medical Journal [Internet]. 2019May31 [cited 2024Nov.2];(3). Available from: http://zmj.zsmu.edu.ua/article/view/168957

Issue

Section

Original research